查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
代謝體學的全球市場:各產品、用途、適應症、最終用途、地區的市場規模調查與預測(2022～2028年)
市場調查報告書
商品編碼
1070306

代謝體學的全球市場:各產品、用途、適應症、最終用途、地區的市場規模調查與預測(2022～2028年)

Global Metabolomics Market Size study, By Product, By Application, By Indication, By End-Use, and Regional Forecasts 2022-2028
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

全球代謝體學的市場規模，2021年約19億美金，預計2022～2028年的預測期間中，以13.4％以上的健全成長率成長。

本報告提供全球代謝體學市場相關調查分析，產業分析，COVID-19影響分析，各產品和服務、用途、適應症、最終用途、地區市場分析，競爭情形相關資訊。

目錄

第1章 摘要整理

第2章 全球代謝體學市場定義和範圍

第3章 全球代謝體學的市場動態

  • 代謝體學市場影響分析(2020～2028年)

第4章 全球代謝體學市場產業分析

  • 波特的五力分析
  • PEST分析
  • 投資採用模式
  • 分析師的推薦事項與結論
  • 主要投資機會
  • 主要winning策略

第5章 風險評估:COVID-19影響

    • COVID-19對產業的整體影響的評估
    • COVID-19前及COVID-19後的市場情境

第6章 全球代謝體學市場:各產品和服務

  • 市場概述
  • 全球代謝體學市場的潛力分析:各產品和服務、效能
  • 全球代謝體學市場估計與預測:各產品和服務(2019～2028年(10億美元))
  • 代謝體學市場:子區隔分析
    • 代謝體學器具
    • 代謝體學生物訊息學的工具和服務

第7章 全球代謝體學市場:各用途

  • 市場概述
  • 全球代謝體學市場的潛力分析:各用途、效能
  • 全球代謝體學市場估計與預測:各用途(2019～2028年(10億美元))
  • 代謝體學市場:子區隔分析
    • 生物標記的發現
    • 藥物研發
    • 毒性檢驗
    • 營養基因學
    • 功能基因學
    • 個人化醫療
    • 其他

第8章 全球代謝體學市場:各適應症

  • 市場概述
  • 全球代謝體學市場的潛力分析:各適應症、效能
  • 全球代謝體學市場估計與預測:各適應症(2019～2028年(10億美元))
  • 代謝體學市場:子區隔分析
    • 癌症
    • 心血管疾病
    • 神經系統疾病
    • 代謝障礙
    • 先天性代謝異常症
    • 其他

第9章 全球代謝體學市場:各最終用途

  • 市場概述
  • 全球代謝體學市場的潛力分析:各最終用途、效能
  • 全球代謝體學市場估計與預測:各最終用途(2019～2028年(10億美元))
  • 代謝體學市場:子區隔分析
    • 學術、研究機關
    • 製藥及生物科技企業
    • 受託研究機構
    • 其他

第10章 全球代謝體學市場:地區分析

  • 各地區市場的概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲概述
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲
  • 亞太地區概述
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 南美概述
    • 巴西
    • 墨西哥
  • 其他地區

第11章 競爭資訊

  • 主要市場策略
  • 企業簡介
    • Waters Corporation
    • Agilent Technologies
    • Shimadzu Corporation
    • Thermo Fisher Scientific
    • Danaher Corporation
    • Bruker Corporation
    • PerkinElmer
    • Merck KGaA
    • GE Healthcare
    • Hitachi High-Technologies Corporation

第12章 調查流程

Global Metabolomics Market is valued approximately USD 1.9 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 13.4% over the forecast period 2022-2028.

Metabolomics is a scientific study of chemical procedures that includes the small molecule substrates, intermediates and products of cell metabolism, and metabolites such as chromatography, spectroscopy, and multivariate. Metabolites are associated with the phenotype of an organism and utilizes in various applications like phenotyping of genetically modified plants, substantial equivalence testing, biotic-abiotic stress reaction analysis, and identification of gene function. Additionally, it also allows scientists and researchers to evaluate biological impacts and perceive the adverse reaction of drugs on an organism. The increasing availability of private and government funding for metabolomics research, and growing expenditure on pharmaceutical and biotech R&D activities are the primary factors for the market growth across the globe. The rising demand for personalized medicine, coupled with the increasing number of strategic movements such as mergers & acquisitions, by the leading market players are further surging the global market demand in the approaching years. For instance, in July 2021, the University of California, Davis (UC Davis), and Thermo Fisher Scientific, Inc. introduced the Center of Excellence in Clinical Metabolomics- a research associate to offer best practices, innovations, and standard operating measures to the metabolomics community. However, the complexity and diversity of biological samples and the high cost of tools and instruments impede the growth of the market over the forecast period of 2022-2028. Also, biomarker development and lucrative opportunities for market growth in emerging markets are anticipated to act as a catalyzing factor for the market demand during the forecast period.

The key regions considered for the global Metabolomics Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing preclinical activities by CROs and pharmaceutical companies, tied with the increasing biomedical research. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as growing demand for improved pharmaceutical products, as well as the growth of the emerging economies, would create lucrative growth prospects for the Metabolomics Market across the Asia-Pacific region.

Major market players included in this report are:

Waters Corporation

Agilent Technologies

Shimadzu Corporation

Thermo Fisher Scientific

Danaher Corporation

Bruker Corporation

PerkinElmer

Merck KGaA

GE Healthcare

Hitachi High-Technologies Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Metabolomics Instruments

Separation Techniques

Detection Techniques

Metabolomics Bioinformatics Tools & Services

By Application:

Biomarker discovery

Drug discovery

Toxicology testing

Nutrigenomics

Functional Genomics

Personalized medicine

Other

By Indication:

Cancer

Cardiovascular Disorders

Neurological Disorders

Metabolic Disorders

Inborn Errors of Metabolism

Other

By End-Use:

Academic and Research Institutes

Pharmaceutical & Biotechnology Companies

Contract Research Organizations

Other

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019,2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Metabolomics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Global Metabolomics Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. Global Metabolomics Market, by Product & Service, 2020-2028 (USD Billion)
    • 1.2.3. Global Metabolomics Market, by Application, 2020-2028 (USD Billion)
    • 1.2.4. Global Metabolomics Market, by Indication, 2020-2028 (USD Billion)
    • 1.2.5. Global Metabolomics Market, by End-Use, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Metabolomics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Metabolomics Market Dynamics

  • 3.1. Metabolomics Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Availability of government and private funding for metabolomics research
      • 3.1.1.2. Increasing demand for personalized medicine
    • 3.1.2. Market Challenges
      • 3.1.2.1. Complexity and diversity of biological samples
      • 3.1.2.2. High cost of tools and instruments
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Biomarker development
      • 3.1.3.2. Lucrative opportunities in emerging markets

Chapter 4. Global Metabolomics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Metabolomics Market, by Product & Service

  • 6.1. Market Snapshot
  • 6.2. Global Metabolomics Market by Product & Service, Performance - Potential Analysis
  • 6.3. Global Metabolomics Market Estimates & Forecasts by Product & Service 2019-2028 (USD Billion)
  • 6.4. Metabolomics Market, Sub Segment Analysis
    • 6.4.1. Metabolomics Instruments
      • 6.4.1.1. Separation Techniques
      • 6.4.1.2. Detection Techniques
    • 6.4.2. Metabolomics Bioinformatics Tools & Services

Chapter 7. Global Metabolomics Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Metabolomics Market by Application, Performance - Potential Analysis
  • 7.3. Global Metabolomics Market Estimates & Forecasts by Application 2019-2028 (USD Billion)
  • 7.4. Metabolomics Market, Sub Segment Analysis
    • 7.4.1. Biomarker Discovery
    • 7.4.2. Drug Discovery
    • 7.4.3. Toxicology Testing
    • 7.4.4. Nutrigenomics
    • 7.4.5. Functional Genomics
    • 7.4.6. Personalized medicine
    • 7.4.7. Other

Chapter 8. Global Metabolomics Market, by Indication

  • 8.1. Market Snapshot
  • 8.2. Global Metabolomics Market by Indication, Performance - Potential Analysis
  • 8.3. Global Metabolomics Market Estimates & Forecasts by Indication 2019-2028 (USD Billion)
  • 8.4. Metabolomics Market, Sub Segment Analysis
    • 8.4.1. Cancer
    • 8.4.2. Cardiovascular Disorders
    • 8.4.3. Neurological Disorders
    • 8.4.4. Metabolic Disorders
    • 8.4.5. Inborn Errors of Metabolism
    • 8.4.6. Other

Chapter 9. Global Metabolomics Market, by End-Use

  • 9.1. Market Snapshot
  • 9.2. Global Metabolomics Market by End-Use, Performance - Potential Analysis
  • 9.3. Global Metabolomics Market Estimates & Forecasts by End-Use 2019-2028 (USD Billion)
  • 9.4. Metabolomics Market, Sub Segment Analysis
    • 9.4.1. Academic and Research Institutes
    • 9.4.2. Pharmaceutical & Biotechnology Companies
    • 9.4.3. Contract Research Organizations
    • 9.4.4. Other

Chapter 10. Global Metabolomics Market, Regional Analysis

  • 10.1. Metabolomics Market, Regional Market Snapshot
  • 10.2. North America Metabolomics Market
    • 10.2.1. U.S. Metabolomics Market
      • 10.2.1.1. Product & Service estimates & forecasts, 2019-2028
      • 10.2.1.2. Application estimates & forecasts, 2019-2028
      • 10.2.1.3. Indication estimates & forecasts, 2019-2028
      • 10.2.1.4. End-Use estimates & forecasts, 2019-2028
    • 10.2.2. Canada Metabolomics Market
  • 10.3. Europe Metabolomics Market Snapshot
    • 10.3.1. U.K. Metabolomics Market
    • 10.3.2. Germany Metabolomics Market
    • 10.3.3. France Metabolomics Market
    • 10.3.4. Spain Metabolomics Market
    • 10.3.5. Italy Metabolomics Market
    • 10.3.6. Rest of Europe Metabolomics Market
  • 10.4. Asia-Pacific Metabolomics Market Snapshot
    • 10.4.1. China Metabolomics Market
    • 10.4.2. India Metabolomics Market
    • 10.4.3. Japan Metabolomics Market
    • 10.4.4. Australia Metabolomics Market
    • 10.4.5. South Korea Metabolomics Market
    • 10.4.6. Rest of Asia Pacific Metabolomics Market
  • 10.5. Latin America Metabolomics Market Snapshot
    • 10.5.1. Brazil Metabolomics Market
    • 10.5.2. Mexico Metabolomics Market
  • 10.6. Rest of The World Metabolomics Market

Chapter 11. Competitive Intelligence

  • 11.1. Top Market Strategies
  • 11.2. Company Profiles
    • 11.2.1. Waters Corporation
      • 11.2.1.1. Key Information
      • 11.2.1.2. Overview
      • 11.2.1.3. Financial (Subject to Data Availability)
      • 11.2.1.4. Product & Service Summary
      • 11.2.1.5. Recent Developments
    • 11.2.2. Agilent Technologies
    • 11.2.3. Shimadzu Corporation
    • 11.2.4. Thermo Fisher Scientific
    • 11.2.5. Danaher Corporation
    • 11.2.6. Bruker Corporation
    • 11.2.7. PerkinElmer
    • 11.2.8. Merck KGaA
    • 11.2.9. GE Healthcare
    • 11.2.10. Hitachi High-Technologies Corporation

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
  • 12.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Metabolomics Market, report scope
  • TABLE 2. Global Metabolomics Market estimates & forecasts by Region 2019-2028 (USD Billion)
  • TABLE 3. Global Metabolomics Market estimates & forecasts by Product & Service 2019-2028 (USD Billion)
  • TABLE 4. Global Metabolomics Market estimates & forecasts by Application 2019-2028 (USD Billion)
  • TABLE 5. Global Metabolomics Market estimates & forecasts by Indication 2019-2028 (USD Billion)
  • TABLE 6. Global Metabolomics Market estimates & forecasts by End-Use 2019-2028 (USD Billion)
  • TABLE 7. Global Metabolomics Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 8. Global Metabolomics Market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 9. Global Metabolomics Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 10. Global Metabolomics Market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 11. Global Metabolomics Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 12. Global Metabolomics Market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 13. Global Metabolomics Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 14. Global Metabolomics Market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 15. Global Metabolomics Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 16. Global Metabolomics Market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 17. U.S. Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 18. U.S. Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 19. U.S. Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 20. Canada Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 21. Canada Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 22. Canada Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 23. UK Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 24. UK Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 25. UK Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 26. Germany Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 27. Germany Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 28. Germany Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 29. RoE Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 30. RoE Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 31. RoE Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 32. China Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 33. China Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 34. China Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 35. India Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 36. India Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 37. India Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 38. Japan Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 39. Japan Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 40. Japan Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 41. RoAPAC Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 42. RoAPAC Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 43. RoAPAC Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 44. Brazil Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 45. Brazil Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 46. Brazil Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 47. Mexico Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 48. Mexico Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 49. Mexico Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 50. RoLA Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 51. RoLA Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 52. RoLA Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 53. Row Metabolomics Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 54. Row Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 55. Row Metabolomics Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 56. List of secondary sources, used in the study of global Metabolomics Market
  • TABLE 57. List of primary sources, used in the study of global Metabolomics Market
  • TABLE 58. Years considered for the study
  • TABLE 59. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Metabolomics Market, research methodology
  • FIG 2. Global Metabolomics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Metabolomics Market, key trends 2021
  • FIG 5. Global Metabolomics Market, growth prospects 2022-2028
  • FIG 6. Global Metabolomics Market, porters 5 force model
  • FIG 7. Global Metabolomics Market, pest analysis
  • FIG 8. Global Metabolomics Market, value chain analysis
  • FIG 9. Global Metabolomics Market by segment, 2019 & 2028 (USD Billion)
  • FIG 10. Global Metabolomics Market by segment, 2019 & 2028 (USD Billion)
  • FIG 11. Global Metabolomics Market by segment, 2019 & 2028 (USD Billion)
  • FIG 12. Global Metabolomics Market by segment, 2019 & 2028 (USD Billion)
  • FIG 13. Global Metabolomics Market by segment, 2019 & 2028 (USD Billion)
  • FIG 14. Global Metabolomics Market, regional snapshot 2019 & 2028
  • FIG 15. North America Metabolomics Market 2019 & 2028 (USD Billion)
  • FIG 16. Europe Metabolomics Market 2019 & 2028 (USD Billion)
  • FIG 17. Asia pacific Market 2019 & 2028 (USD Billion)
  • FIG 18. Latin America Metabolomics Market 2019 & 2028 (USD Billion)
  • FIG 19. Global Metabolomics Market, company Market share analysis (2021)